These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2426494)

  • 21. [Reflexions on the palliative surgical treatment of prostatic cancer].
    Schimmel F
    J Urol Nephrol (Paris); 1971; 77(10):839-48. PubMed ID: 4108255
    [No Abstract]   [Full Text] [Related]  

  • 22. Activities of living. Three. A problem of elimination.
    Awenat Y
    Nurs Times; 1984 May 2-8; 80(18):53. PubMed ID: 6201829
    [No Abstract]   [Full Text] [Related]  

  • 23. FAQs: lower urinary tract symptoms in men.
    Belal M; Abrams P
    Practitioner; 2004 Sep; 248(1662):652, 654, 656 passim. PubMed ID: 15376550
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cryotherapy of urinary retention in inoperable patients].
    Togni G; Gridelli F
    Minerva Med; 1974 Oct; 65(70):3712-3. PubMed ID: 4138731
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of so-called prostatic hypertrophy with endovesical projection of the lateral lobes].
    Iavarone C; Battisti G; Brescia A; Marigliani M; Messinetti S
    G Chir; 1989 Mar; 10(3):109-10. PubMed ID: 2484675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological treatment of urination disorders in congestive inflammatory and "hypertrophic" diseases of the prostate].
    SCULTETY S
    Z Urol; 1961 Apr; 54():219-26. PubMed ID: 13749456
    [No Abstract]   [Full Text] [Related]  

  • 27. I-PSS and type of treatment.
    Rizzo M; Tosto A; Benvenuti F; Del Popolo G
    J Urol (Paris); 1995; 101(1):46-9. PubMed ID: 7545730
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of gestagens on the symptoms of prostatic hypertrophy].
    Graber P; Leibundgut B
    Urologe A; 1972 Nov; 11(6):326-9. PubMed ID: 4118967
    [No Abstract]   [Full Text] [Related]  

  • 29. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules].
    Hallwachs O
    MMW Munch Med Wochenschr; 1981 Oct; 123(44):1675-6. PubMed ID: 6171728
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medroxyprogesterone acetate in urinary retention caused by inoperable prostatic hypertrophy].
    Menozzi D; Debbia F
    Minerva Urol; 1970; 22(3):89-105. PubMed ID: 4099514
    [No Abstract]   [Full Text] [Related]  

  • 31. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
    Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
    Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urination disorders in middle-aged men. Adenoma and carcinoma of the prostate].
    Nagel R
    Med Monatsschr; 1968 Apr; 22(4):153-9. PubMed ID: 4177968
    [No Abstract]   [Full Text] [Related]  

  • 33. Retention of urine due to simple prostatic enlargement: treatment by prostatic injection.
    Reddington B
    Nurs Times; 1968 Aug; 64(35):1171-2. PubMed ID: 4175059
    [No Abstract]   [Full Text] [Related]  

  • 34. [Transurethral resection in prostatic obstructive pathology: our experience in recent years].
    Taño Pino FJ; Galbis Palau F
    Arch Esp Urol; 1988 Apr; 41(3):183-7. PubMed ID: 2456745
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current status of the treatment and prognosis of the prostatic urine retention].
    Bibus B
    Wien Klin Wochenschr; 1967 Feb; 79(6):105-8. PubMed ID: 4173547
    [No Abstract]   [Full Text] [Related]  

  • 36. Benign prostatic hyperplasia (BHP) and bothersome voiding symptoms.
    Hald T
    J Urol (Paris); 1995; 101(1):7-9. PubMed ID: 7545735
    [No Abstract]   [Full Text] [Related]  

  • 37. [Urethral resistance and bladder contractility].
    Susset J
    Ann Urol (Paris); 1993; 27(5):280-3. PubMed ID: 7508214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Delayed adenomectomy].
    Tiktinskiĭ OL; Aletin RR; Novikov IF
    Urol Nefrol (Mosk); 1973; 38(4):36-9. PubMed ID: 4132398
    [No Abstract]   [Full Text] [Related]  

  • 39. The urodynamic assessment of benign prostatic hyperplasia obstruction.
    Artibani W
    J Urol (Paris); 1995; 101(1):42-4. PubMed ID: 7545728
    [No Abstract]   [Full Text] [Related]  

  • 40. Measurements of urethral resistance.
    DAVIS JE; MORILLO M; DRAPER JW
    J Urol; 1961 Apr; 85():586-92. PubMed ID: 13720188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.